Trial intelligence / Profile preview

High Dose Dual vs Sequential vs Triple Therapy for H. Pylori Eradication

NCT01163435Phase 4Completed

Sponsor
National Taiwan University Hospital
Start
Aug 2010
Primary completion
Jul 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of rabeprazole, amoxicillin, clarithromycin, metronidazole, levofloxacin in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Started Aug 2010; status: completed.

02

Drugs

rabeprazoleamoxicillinclarithromycinmetronidazolelevofloxacin
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT01163435.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01163435.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call